Spectrum announces various clinical studies on ZEVALIN at ICML 2011
Links shared publicly online about this topic.
- 205total visits
Spectrum announces various clinical studies on ZEVALIN at ICML 2011
Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology, today announced that various studies on ZEVALIN for Injection were presented at the 11th International Conference on Malignant Lymphoma (ICML), held June 15-18, 2011, in Lugano, Switzerland.
View full resource at news-medical.net
Tags: Lymphoma, Drug, Pharma, Biotech, Oncology, Surgery, News
Most Recently Shared on June 20, 2011 at 2:32 pm By:
Oncology News: Spectrum announces various clinical studies on ZEVALIN at ICML 2011: Spectrum Pharmaceuticals, a ... http://bit.ly/m0fcSV
Advertisement
